Cargando…
Incidence of cetuximab-related infusion reaction in head and neck cancer patients: may we predict it?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6012560/ https://www.ncbi.nlm.nih.gov/pubmed/29942669 http://dx.doi.org/10.1136/esmoopen-2018-000404 |
| _version_ | 1783333936888283136 |
|---|---|
| author | Merlano, Marco C Garrone, Ornella |
| author_facet | Merlano, Marco C Garrone, Ornella |
| author_sort | Merlano, Marco C |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6012560 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-60125602018-06-25 Incidence of cetuximab-related infusion reaction in head and neck cancer patients: may we predict it? Merlano, Marco C Garrone, Ornella ESMO Open Editorial BMJ Publishing Group 2018-06-20 /pmc/articles/PMC6012560/ /pubmed/29942669 http://dx.doi.org/10.1136/esmoopen-2018-000404 Text en © European Society for Medical Oncology (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| spellingShingle | Editorial Merlano, Marco C Garrone, Ornella Incidence of cetuximab-related infusion reaction in head and neck cancer patients: may we predict it? |
| title | Incidence of cetuximab-related infusion reaction in head and neck cancer patients: may we predict it? |
| title_full | Incidence of cetuximab-related infusion reaction in head and neck cancer patients: may we predict it? |
| title_fullStr | Incidence of cetuximab-related infusion reaction in head and neck cancer patients: may we predict it? |
| title_full_unstemmed | Incidence of cetuximab-related infusion reaction in head and neck cancer patients: may we predict it? |
| title_short | Incidence of cetuximab-related infusion reaction in head and neck cancer patients: may we predict it? |
| title_sort | incidence of cetuximab-related infusion reaction in head and neck cancer patients: may we predict it? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6012560/ https://www.ncbi.nlm.nih.gov/pubmed/29942669 http://dx.doi.org/10.1136/esmoopen-2018-000404 |
| work_keys_str_mv | AT merlanomarcoc incidenceofcetuximabrelatedinfusionreactioninheadandneckcancerpatientsmaywepredictit AT garroneornella incidenceofcetuximabrelatedinfusionreactioninheadandneckcancerpatientsmaywepredictit |